The association between overall survival and the total number of dissected lymph nodes: An artifact caused by the surgical pathologist?

Annals of Surgery

Volumn 249, Issue 4, 2009, Pages 693-694

  Metze, Konradin ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CANCER SURVIVAL; COLON CANCER; ESOPHAGUS CANCER; HUMAN; LETTER; LYMPH NODE DISSECTION; PATHOLOGIST; PRIORITY JOURNAL; PROGNOSIS; ANALYSIS OF VARIANCE; ARTIFACT; BRAZIL; ESOPHAGUS TUMOR; LYMPH NODE; LYMPHADENECTOMY; MORTALITY; NOTE; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STANDARD; STATISTICS; SURVIVAL; THEORETICAL MODEL;

ANALYSIS OF VARIANCE; ARTIFACTS; BRAZIL; ESOPHAGEAL NEOPLASMS; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MODELS, THEORETICAL; NEOPLASM STAGING; PATHOLOGY, CLINICAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 65449121159     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/01.sla.0000348714.87392.94     Document Type: Letter

References (17)

1. Altorki NK, Zhou XK, Stiles B, et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg. 2008;248:221-226.
2. Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg. 2006;244:602-610.
3. Wijnhoven BP, Tran KT, Esterman A, et al. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg. 2007;245:717-25.
4. Mariette C, Piessen G, Briez N, et al. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg. 2008;247: 365-371.
5. Paradis C. Bias in surgical research. Ann Surg. 2008;248:180-188.
6. Metze K. Methodological aspects of prognostic factor studies: some caveats. Sao Paulo Med J. 1998;116:1787-1788.
7. Metze K. Methodological problems of grading tumour regression: responders compared to non-responders. J Cancer Res Clin Oncol. 1998;124:281-282.
8. Metze K, Adam RL. Quantification in histopa-thology-some pitfalls. Braz J Med Biol Res. 2005;38:141-143.
9. Metze K. Dichotomization of continuous data - a pitfall in prognostic factor studies. Pathol Res Pract. 2008;204:213-214.
10. Bogoevski D, Onken F, Koenig A, et al. Is it time for a new TNM classification in esophageal carcinoma? Ann Surg. 2008;247:633-641.
11. Marchet A, Mocellin S, Ambrosi A, et al. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg. 2007; 245:543-552.
12. Lorand-Metze I, Pinheiro MP, Ribeiro E, et al. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications. Leuk Res. 2004;28:587-594.
13. Delamain MT, Metze K, Marques JF Jr, et al. Optimization of CD34+ collection for autologous transplantation using the evolution of peripheral blood cell counts after mobilization with chemotherapy and G-CSF. Transfus Apher Sci. 2006;34:33-40.
14. Adam RL, Silva RC, Pereira FG, et al. The fractal dimension of nuclear chromatin as a prognostic factor in acute precursor B lymphoblastic leukemia. Cell Oncol. 2006;28:55-59.
15. Metze K, Lobo AM, Lorand-Metze I. Nucleolus organizer regions (AgNORs) and total tumor mass are independent prognostic parameters for treatment-free period in chronic lymphocytic leukemia. Int J Cancer. 2000;89:440-443.
16. Metze K, Chiari AC, Andrade FL, et al. Changes in AgNOR configurations during the evolution and treatment of chronic lymphocytic leukemia. Hematol Cell Ther. 1999;41:205-210.
17. Lorand-Metze I, Meira DG, Lima CS, et al. The differential diagnosis between aplastic anemia and hypocellular myelodysplasia in patients with pancytopenia. Haematologica 1999;84: 564-565.